The effect of ropinirole on apathy and depression after herpes encephalitis.

We describe a 76-year-old man with herpes encephalitis whose symptom of severe apathy was improved by the dopamine D2/D3 receptor agonist ropinirole. Brain magnetic resonance imaging had shown lesions in the patient's right mesial temporal cortex, right insula, and bilateral medial frontal regions. During treatment with acyclovir, he had developed severe apathy and depression. On neuropsychological assessment, he scored 21/30 points on the Mini-Mental State Examination, 30/42 on the Starkstein Apathy Scale (cutoff score =16), and 59/80 on the Zung Self-Rating Depression Scale (cutoff score=40). We then started him on ropinirole 0.25 mg/day. Over the next 10 days, his apathy and depression gradually improved. On day 10 of treatment, follow-up testing showed that his Apathy Scale score had improved to 25 points. This case suggests that a low dose of a dopamine receptor agonist may be an effective treatment for patients who develop apathy and depression after encephalitis.

[1]  K. Dujardin,et al.  Proposed diagnostic criteria for apathy in Alzheimer’s disease and other neuropsychiatric disorders , 2009, European Psychiatry.

[2]  K. Barrett.  Treating organic abulia with bromocriptine and lisuride: four case studies. , 1991, Journal of neurology, neurosurgery, and psychiatry.

[3]  Kazunori Okada,et al.  Assessment of motivational loss in post-stroke patients using the Japanese version of Stark-stein's Apathy scale , 1998 .

[4]  M. Alexander,et al.  Outpatient rehabilitation of patients with chronic cognitive impairments after ruptured anterior communicating artery aneurysms reduces the burden of care: A pilot study , 2006, Brain injury.

[5]  H. Bokura,et al.  Successful treatment of post-stroke apathy by the dopamine receptor agonist ropinirole , 2010, Journal of Clinical Neuroscience.

[6]  R. Tate,et al.  Apathy after acquired brain impairment: A systematic review of non-pharmacological interventions , 2009, Neuropsychological rehabilitation.

[7]  W. Jost,et al.  [Improvements in motor and non-motor symptoms in parkinson patients under ropinirole therapy]. , 2007, Fortschritte der Neurologie-Psychiatrie.

[8]  R. Greenwood,et al.  Motivational deficits after brain injury: effects of bromocriptine in 11 patients. , 1996, Journal of neurology, neurosurgery, and psychiatry.

[9]  S. Kobayashi,et al.  [A study on a self-rating depression scale (author's transl)]. , 1973, Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica.

[10]  A. Verier,et al.  Cognitive and psychiatric impairment in herpes simplex virus encephalitis suggest involvement of the amygdalo-frontal pathways , 1996, Journal of Neurology.

[11]  O. Salonen,et al.  Cognitive impairment after acute encephalitis: comparison of herpes simplex and other aetiologies. , 1996, Journal of neurology, neurosurgery, and psychiatry.

[12]  Y. Agid,et al.  Apathy following subthalamic stimulation in Parkinson disease: A dopamine responsive symptom , 2008, Movement disorders : official journal of the Movement Disorder Society.

[13]  F. Tagliavini,et al.  "Thalamic" dementia in herpes encephalitis: clinico-pathological report. , 1981, Acta neuropathologica. Supplementum.

[14]  Roy W Jones,et al.  Effect of donepezil on emergence of apathy in mild to moderate Alzheimer's disease , 2011, International journal of geriatric psychiatry.

[15]  B. Dubois,et al.  Apathy and the functional anatomy of the prefrontal cortex-basal ganglia circuits. , 2006, Cerebral cortex.